![Stephen Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Thomas
Directeur/Bestuurslid bij
CLIMB BIO, INC.
Vermogen: 2 M $ op 30-06-2026
Profiel
Stephen Thomas is the founder of Sera Medicines LLC, founded in 2023, serving as Chief Executive Officer & Director.
Dr. Thomas was the founder of Climb Bio Operating, Inc., founded in 2023, and served as Chief Executive Officer & Director from 2023 to 2024.
Dr. Thomas was the founder of Ichorion Therapeutics, Inc., founded in 2017, and served as Chief Scientific Officer from 2017 to 2018.
Dr. Thomas currently works as Director at Climb Bio, Inc. starting in 2024.
Former jobs include Chief Executive Officer & Director at Navigator Medicines, Inc. from 2024 to 2025, Chief Scientific Officer at ValenzaBio, Inc. from 2020 to 2023, and Vice President & Head-Discovery at Avalo Therapeutics, Inc. from 2018 to 2020.
Education includes graduate and doctorate degrees from The Trustees of Columbia University in The City of New York and an undergraduate degree from Rensselaer Polytechnic Institute.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CLIMB BIO, INC. 0,27% | 05-06-2026 | 154.657 ( 0,27% ) | 2 M $ | 30-06-2026 |
Actieve functies van Stephen Thomas
| Bedrijven | Functie | Begin |
|---|---|---|
| CLIMB BIO, INC. | Directeur/Bestuurslid | 27-06-2024 |
Eerdere bekende functies van Stephen Thomas
| Bedrijven | Functie | Einde |
|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2020 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Oprichter | 01-09-2018 |
Opleiding van Stephen Thomas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
